27 September 2021 | News
QMS-MAS will be conducting remote diabetic retinopathy screening pan India using VISUSCOUT 100 camera of ZEISS
Image Credit: QMS-MAS
QMS Medical Allied Services (MAS) has announced a strategic arrangement with ZEISS Medical Technology India - for the screening of diabetic retinopathy.
With this arrangement, Mumbai-based QMS-MAS is making its entry in the field of conducting medical camps across locations in India.
QMS-MAS will be conducting remote diabetic retinopathy screening pan India using VISUSCOUT 100 camera of ZEISS.
“We will be offering various other preventive medical camps. With this initiative, we hope to make the healthcare delivery system more effective by early detection and timely referral of patients to improve therapy outcomes. ZEISS is a perfect partner in this step towards investing in the future of healthcare,” said Mahesh Makhija, MD, QMS Medical Allied Services.
VISUSCOUT 100 camera is a handheld fundus camera and a perfect imaging companion for reliably detecting and monitoring retinal disorders. Due to its lightweight and compact design, it is easily moveable and works perfectly for health care professionals interested in an easy, cost-effective fundus imaging solution.
QMS-MAS is going to conduct these screenings along with multiple other tests using ground-breaking point of care medical devices, under the banner of Unified Medicare (UMC).